NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/20/2025
Back to search
Official data from USPTO
KALVISTA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
KALVISTA
ST13
US500000079351011Class
5, 10, 42, 44
Filing
79351011
Registration
7147580
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
11/21/2025
Trademark type
Word
Nice classes
5, 10, 42, 44
Filing date
07/20/2022
Registration date
08/29/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/29/2023
Last transaction
11/21/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
JOINER,KATINA JACKSON
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Kalvista Pharmaceuticals Limited
Representatives
Stacy L. Wu Cast Legal Studio PLLC
Technical classification
Nice Classes
Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of ophthalmic diseases and disorders; pharmaceutical preparations for the treatment of diabetic macular edema; pharmaceutical preparations for the treatment of angioedema; pharmaceutical preparations for the treatment of hereditary angioedema; pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders
Class 10
Medical and surgical instruments and apparatus for use in the treatment of ophthalmic diseases and disordersdiabetic macular edemaangioedemahereditary angioedemadiseases and disorders mediated by the contact activation systemplasma kallikrein or factor XIIa mediated diseases or disorders; drug delivery devices for use in the treatment of ophthalmic diseases and disordersdiabetic macular edemaangioedemahereditary angioedemadiseases and disorders mediated by the contact activation systemplasma kallikrein or factor XIIa mediated diseases or disorders
Class 42
Drug discovery services relating to ophthalmic diseases and disorders; drug discovery services relating to diabetic macular edema; drug discovery services relating to angioedema; drug discovery services relating to hereditary angioedema; drug discovery services relating to diseases and disorders mediated by the contact activation system; drug discovery services relating to plasma kallikrein or factor XIIa mediated diseases or disorders
Class 44
Medical and healthcare services relating to ophthalmic diseases and disorders; medical and health care services relating to diabetic macular edema; medical and healthcare services relating to angioedema; medical and healthcare services relating to hereditary angioedema; medical and healthcare services relating to diseases and disorders mediated by the contact activation system; medical and healthcare services relating to plasma kallikrein or factor XIIa mediated diseases or disorders
Publications
History of USPTO decisions and trademark events.
18 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/09/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/09/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/09/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/09/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/09/2025
GPNX
NOTIFICATION PROCESSED BY IB
10/23/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/29/2023
FIMP
FINAL DISPOSITION PROCESSED
09/29/2023
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
09/28/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
08/29/2023
PUBO
PUBLISHED FOR OPPOSITION
06/13/2023
NPUB
NOTICE OF PUBLICATION
05/24/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/06/2023
DOCK
ASSIGNED TO EXAMINER
05/05/2023
MAFR
APPLICATION FILING RECEIPT MAILED
10/04/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/30/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/29/2022
Continuous trademark protection
Get notified about every new filing that threatens KALVISTA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.